This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mackett, M
Right arrow Articles by Moss, B
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mackett, M
Right arrow Articles by Moss, B

 Previous Article  |  Next Article 

J Virol. 1984 March; 49(3): 857-864

General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes.

M Mackett, G L Smith and B Moss

ABSTRACT

The production and selection of infectious vaccinia virus recombinants expressing foreign genes was facilitated by the construction of plasmid vectors. These vectors contain all or part of the vaccinia virus thymidine kinase (TK) gene interrupted by multiple unique restriction endonuclease sites placed adjacent to the TK promoter or another promoter translocated within the TK gene. The insertion of a continuous coding sequence for a foreign protein at one of the unique restriction endonuclease sites juxtaposes the transcriptional start site of a vaccinia promoter and the translational start site of a foreign gene. After transfection of vaccinia virus-infected cells with such plasmids, homologous recombination occurs between the vaccinia virus sequences flanking the chimeric gene and the same sequences within the virus genome. Recombinants formed in this manner have the chimeric gene inserted within the body of the vaccinia virus TK gene under control of a vaccinia virus promoter. Since recombinants have an interrupted TK gene, they are selected on the basis of their TK- phenotype and then checked for the presence and expression of the foreign gene. Infectious recombinant viruses expressing the procaryotic enzyme chloramphenicol acetyltransferase were constructed to optimize the system. The absence of chloramphenicol acetyltransferase activity in uninfected cells or in cells infected with wild-type vaccinia virus and the availability of a sensitive and quantitative enzyme assay allowed an estimation of the relative strengths of various promoter constructs. The expression of chloramphenicol acetyltransferase was detected within 1 h after infection of cells with recombinant virus, reflecting the early nature of the promoters used.

J Virol. 1984 March; 49(3): 857-864




This article has been cited by other articles:

  • Satheshkumar, P. S., Anton, L. C., Sanz, P., Moss, B. (2009). Inhibition of the Ubiquitin-Proteasome System Prevents Vaccinia Virus DNA Replication and Expression of Intermediate and Late Genes. J. Virol. 83: 2469-2479 [Abstract] [Full Text]  
  • Whittaker, G. C., Burshtyn, D. N., Orr, S. J., Quigley, L., Hodge, D. L., Pascal, V., Zhang, W., McVicar, D. W. (2008). Analysis of the linker for activation of T cells and the linker for activation of B cells in natural killer cells reveals a novel signaling cassette, dual usage in ITAM signaling, and influence on development of the Ly49 repertoire. Blood 112: 2869-2877 [Abstract] [Full Text]  
  • Wong, S. B. J., Bos, R., Sherman, L. A. (2008). Tumor-Specific CD4+ T Cells Render the Tumor Environment Permissive for Infiltration by Low-Avidity CD8+ T Cells. J. Immunol. 180: 3122-3131 [Abstract] [Full Text]  
  • Fleming, S. B., Anderson, I. E., Thomson, J., Deane, D. L., McInnes, C. J., McCaughan, C. A., Mercer, A. A., Haig, D. M. (2007). Infection with recombinant orf viruses demonstrates that the viral interleukin-10 is a virulence factor. J. Gen. Virol. 88: 1922-1927 [Abstract] [Full Text]  
  • Najarro, P., Gubser, C., Hollinshead, M., Fox, J., Pease, J., Smith, G. L. (2006). Yaba-like disease virus chemokine receptor 7L, a CCR8 orthologue.. J. Gen. Virol. 87: 809-816 [Abstract] [Full Text]  
  • Fayad, R., Zhang, H., Quinn, D., Huang, Y., Qiao, L. (2004). Oral Administration with Papillomavirus Pseudovirus Encoding IL-2 Fully Restores Mucosal and Systemic Immune Responses to Vaccinations in Aged Mice. J. Immunol. 173: 2692-2698 [Abstract] [Full Text]  
  • Fassnacht, U., Ackermann, A., Staeheli, P., Hausmann, J. (2004). Immunization with dendritic cells can break immunological ignorance toward a persisting virus in the central nervous system and induce partial protection against intracerebral viral challenge. J. Gen. Virol. 85: 2379-2387 [Abstract] [Full Text]  
  • Gil, J., Garcia, M. A., Gomez-Puertas, P., Guerra, S., Rullas, J., Nakano, H., Alcami, J., Esteban, M. (2004). TRAF Family Proteins Link PKR with NF-{kappa}B Activation. Mol. Cell. Biol. 24: 4502-4512 [Abstract] [Full Text]  
  • Ortmann, D., Hausmann, J., Beuschlein, F., Schmenger, K., Stahl, M., Geissler, M., Reincke, M. (2004). Steroidogenic Acute Regulatory (StAR)-Directed Immunotherapy Protects against Tumor Growth of StAR-Expressing Sp2-0 Cells in a Rodent Adrenocortical Carcinoma Model. Endocrinology 145: 1760-1766 [Abstract] [Full Text]  
  • Earl, P. L., Americo, J. L., Moss, B. (2003). Development and Use of a Vaccinia Virus Neutralization Assay Based on Flow Cytometric Detection of Green Fluorescent Protein. J. Virol. 77: 10684-10688 [Abstract] [Full Text]  
  • McKelvey, T. A., Andrews, S. C., Miller, S. E., Ray, C. A., Pickup, D. J. (2002). Identification of the Orthopoxvirus p4c Gene, Which Encodes a Structural Protein That Directs Intracellular Mature Virus Particles into A-Type Inclusions. J. Virol. 76: 11216-11225 [Abstract] [Full Text]  
  • Domi, A., Moss, B. (2002). Cloning the vaccinia virus genome as a bacterial artificial chromosome in Escherichia coli and recovery of infectious virus in mammalian cells. Proc. Natl. Acad. Sci. USA 99: 12415-12420 [Abstract] [Full Text]  
  • Panus, J. F., Smith, C. A., Ray, C. A., Smith, T. D., Patel, D. D., Pickup, D. J. (2002). Cowpox virus encodes a fifth member of the tumor necrosis factor receptor family: A soluble, secreted CD30 homologue. Proc. Natl. Acad. Sci. USA 99: 8348-8353 [Abstract] [Full Text]  
  • Lewicki, D. N., Gallagher, T. M. (2002). Quaternary Structure of Coronavirus Spikes in Complex with Carcinoembryonic Antigen-related Cell Adhesion Molecule Cellular Receptors. J. Biol. Chem. 277: 19727-19734 [Abstract] [Full Text]  
  • Tourdot, S., Herath, S., Gould, K. G. (2001). Characterization of a new H-2Dk-restricted epitope prominent in primary influenza A virus infection. J. Gen. Virol. 82: 1749-1755 [Abstract] [Full Text]  
  • Krueger, D. K., Kelly, S. M., Lewicki, D. N., Ruffolo, R., Gallagher, T. M. (2001). Variations in Disparate Regions of the Murine Coronavirus Spike Protein Impact the Initiation of Membrane Fusion. J. Virol. 75: 2792-2802 [Abstract] [Full Text]  
  • Savory, L. J., Stacker, S. A., Fleming, S. B., Niven, B. E., Mercer, A. A. (2000). Viral Vascular Endothelial Growth Factor Plays a Critical Role in Orf Virus Infection. J. Virol. 74: 10699-10706 [Abstract] [Full Text]  
  • Chung, Y.-H., Jun, H. S., Son, M., Bao, M., Bae, H. Y., Kang, Y., Yoon, J.-W. (2000). Cellular and Molecular Mechanism for Kilham Rat Virus-Induced Autoimmune Diabetes in DR-BB Rats. J. Immunol. 165: 2866-2876 [Abstract] [Full Text]  
  • Spencer, J. V., Braciale, T. J. (2000). Incomplete Cd8+ T Lymphocyte Differentiation as a Mechanism for Subdominant Cytotoxic T Lymphocyte Responses to a Viral Antigen. JEM 191: 1687-1698 [Abstract] [Full Text]  
  • Stittelaar, K. J., Wyatt, L. S., de Swart, R. L., Vos, H. W., Groen, J., van Amerongen, G., van Binnendijk, R. S., Rozenblatt, S., Moss, B., Osterhaus, A. D. M. E. (2000). Protective Immunity in Macaques Vaccinated with a Modified Vaccinia Virus Ankara-Based Measles Virus Vaccine in the Presence of Passively Acquired Antibodies. J. Virol. 74: 4236-4243 [Abstract] [Full Text]  
  • Eder, J. P., Kantoff, P. W., Roper, K., Xu, G., Bubley, G. J., Boyden, J., Gritz, L., Mazzara, G., Oh, W. K., Arlen, P., Tsang, K. Y., Panicali, D., Schlom, J., Kufe, D. W. (2000). A Phase I Trial of a Recombinant Vaccinia Virus Expressing Prostate-specific Antigen in Advanced Prostate Cancer. Clin. Cancer Res. 6: 1632-1638 [Abstract] [Full Text]  
  • Traktman, P., Liu, K., DeMasi, J., Rollins, R., Jesty, S., Unger, B. (2000). Elucidating the Essential Role of the A14 Phosphoprotein in Vaccinia Virus Morphogenesis: Construction and Characterization of a Tetracycline-Inducible Recombinant. J. Virol. 74: 3682-3695 [Abstract] [Full Text]  
  • Morello, C. S., Cranmer, L. D., Spector, D. H. (2000). Suppression of Murine Cytomegalovirus (MCMV) Replication with a DNA Vaccine Encoding MCMV M84 (a Homolog of Human Cytomegalovirus pp65). J. Virol. 74: 3696-3708 [Abstract] [Full Text]  
  • Coupar, B. E. H., Oke, P. G., Andrew, M. E. (2000). Insertion sites for recombinant vaccinia virus construction: effects on expression of a foreign protein. J. Gen. Virol. 81: 431-439 [Abstract] [Full Text]  
  • Davis, N. L., Caley, I. J., Brown, K. W., Betts, M. R., Irlbeck, D. M., McGrath, K. M., Connell, M. J., Montefiori, D. C., Frelinger, J. A., Swanstrom, R., Johnson, P. R., Johnston, R. E. (2000). Vaccination of Macaques against Pathogenic Simian Immunodeficiency Virus with Venezuelan Equine Encephalitis Virus Replicon Particles. J. Virol. 74: 371-378 [Abstract] [Full Text]  
  • Daenke, S, Booth, S (2000). HTLV-1-induced cell fusion is limited at two distinct steps in the fusion pathway after receptor binding. J. Cell Sci. 113: 37-44 [Abstract]  
  • An, S., Chen, C.-J., Yu, X., Leibowitz, J. L., Makino, S. (1999). Induction of Apoptosis in Murine Coronavirus-Infected Cultured Cells and Demonstration of E Protein as an Apoptosis Inducer. J. Virol. 73: 7853-7859 [Abstract] [Full Text]  
  • Stevenson, P. G., Belz, G. T., Castrucci, M. R., Altman, J. D., Doherty, P. C. (1999). A gamma -herpesvirus sneaks through a CD8+ T cell response primed to a lytic-phase epitope. Proc. Natl. Acad. Sci. USA 96: 9281-9286 [Abstract] [Full Text]  
  • Lewis, A. J., Whitton, J. L., Hatalski, C. G., Weissenböck, H., Lipkin, W. I. (1999). Effect of Immune Priming on Borna Disease. J. Virol. 73: 2541-2546 [Abstract] [Full Text]  
  • Villacres, M. C., Bergmann, C. C. (1999). Enhanced Cytotoxic T Cell Activity in IL-4-Deficient Mice. J. Immunol. 162: 2663-2670 [Abstract] [Full Text]  
  • Blaney, J. E. Jr., Nobusawa, E., Brehm, M. A., Bonneau, R. H., Mylin, L. M., Fu, T.-M., Kawaoka, Y., Tevethia, S. S. (1998). Immunization with a Single Major Histocompatibility Complex Class I-Restricted Cytotoxic T-Lymphocyte Recognition Epitope of Herpes Simplex Virus Type 2 Confers Protective Immunity. J. Virol. 72: 9567-9574 [Abstract] [Full Text]  
  • Olson, L. J., Ho, B. Y., Cashdollar, L. W., Drewett, J. G. (1998). Functionally Active Catalytic Domain Is Essential for Guanylyl Cyclase-Linked Receptor Mediated Inhibition of Human Aldosterone Synthesis. Mol. Pharmacol. 54: 761-769 [Abstract] [Full Text]  
  • Henke, A., Wagner, E., Whitton, J. L., Zell, R., Stelzner, A. (1998). Protection of Mice against Lethal Coxsackievirus B3 Infection by Using DNA Immunization. J. Virol. 72: 8327-8331 [Abstract] [Full Text]  
  • Wessely, R., Henke, A., Zell, R., Kandolf, R., Knowlton, K. U. (1998). Low-Level Expression of a Mutant Coxsackieviral cDNA Induces a Myocytopathic Effect in Culture : An Approach to the Study of Enteroviral Persistence in Cardiac Myocytes. Circulation 98: 450-457 [Abstract] [Full Text]  
  • Yamanaka, M. K., Yilma, T. (1998). Altered Plaque Formation by Recombinant Vaccinia Virus Expressing Simian Immunodeficiency Virus Nef. J. Virol. 72: 5291-5295 [Abstract] [Full Text]  
  • Richt, J. A., Furbringer, T., Koch, A., Pfeuffer, I., Herden, C., Bause-Niedrig, I., Garten, W. (1998). Processing of the Borna Disease Virus Glycoprotein gp94 by the Subtilisin-Like Endoprotease Furin. J. Virol. 72: 4528-4533 [Abstract] [Full Text]  
  • Kittlesen, D. J., Thompson, L. W., Gulden, P. H., Skipper, J. C. A., Colella, T. A., Shabanowitz, J. A., Hunt, D. F., Engelhard, V. H., Slingluff, C. L. Jr. (1998). Human Melanoma Patients Recognize an HLA-A1-Restricted CTL Epitope from Tyrosinase Containing Two Cysteine Residues: Implications for Tumor Vaccine Development. J. Immunol. 160: 2099-2106 [Abstract] [Full Text]  
  • Kim, M. J., Min, D. S., Ryu, S. H., Suh, P.-G. (1998). A Cytosolic, Galpha q- and beta gamma -insensitive Splice Variant of Phospholipase C-beta 4. J. Biol. Chem. 273: 3618-3624 [Abstract] [Full Text]  
  • Fu, T.-M., Mylin, L. M., Schell, T. D., Bacik, I., Russ, G., Yewdell, J. W., Bennink, J. R., Tevethia, S. S. (1998). An Endoplasmic Reticulum-Targeting Signal Sequence Enhances the Immunogenicity of an Immunorecessive Simian Virus 40 Large T Antigen Cytotoxic T-Lymphocyte Epitope. J. Virol. 72: 1469-1481 [Abstract] [Full Text]  
  • Mosse, C. A., Meadows, L., Luckey, C. J., Kittlesen, D. J., Huczko, E. L., Slingluff, C. L. Jr., Shabanowitz, J., Hunt, D. F., Engelhard, V. H. (1998). The Class I Antigen-processing Pathway for the Membrane Protein Tyrosinase Involves Translation in the Endoplasmic Reticulum and Processing in the Cytosol. JEM 187: 37-48 [Abstract] [Full Text]  
  • Diamond, D. J., York, J., Sun, J.-Y., Wright, C. L., Forman, S. J. (1997). Development of a Candidate HLA A*0201 Restricted Peptide-Based Vaccine Against Human Cytomegalovirus Infection. Blood 90: 1751-1767 [Abstract] [Full Text]  
  • Bronte, V., Carroll, M. W., Goletz, T. J., Wang, M., Overwijk, W. W., Marincola, F., Rosenberg, S. A., Moss, B., Restifo, N. P. (1997). Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine. Proc. Natl. Acad. Sci. USA 94: 3183-3188 [Abstract] [Full Text]  
  • Steinhauer, D. A., Martin, J., Lin, Y. P., Wharton, S. A., Oldstone, M. B. A., Skehel, J. J., Wiley, D. C. (1996). Studies using double mutants of the conformational transitions in influenza hemagglutinin required for its membrane fusion activity. Proc. Natl. Acad. Sci. USA 93: 12873-12878 [Abstract] [Full Text]  
  • Pazin, M J, Sheridan, P L, Cannon, K, Cao, Z, Keck, J G, Kadonaga, J T, Jones, K A (1996). NF-kappa B-mediated chromatin reconfiguration and transcriptional activation of the HIV-1 enhancer in vitro.. Genes Dev. 10: 37-49 [Abstract]  
  • Rindisbacher, L., Cottet, S., Wittek, R., Kraehenbuhl, J.-P., Corthésy, B. (1995). Production of Human Secretory Component with Dimeric IgA Binding Capacity Using Viral Expression Systems. J. Biol. Chem. 270: 14220-14228 [Abstract] [Full Text]  
  • Zomerdijk, J., Beckmann, H, Comai, L, Tjian, R (1994). Assembly of transcriptionally active RNA polymerase I initiation factor SL1 from recombinant subunits. Science 266: 2015-2018 [Abstract]  
  • Murakami, M, Hibi, M, Nakagawa, N, Nakagawa, T, Yasukawa, K, Yamanishi, K, Taga, T, Kishimoto, T (1993). IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase. Science 260: 1808-1810 [Abstract]  
  • Moss, B (1991). Vaccinia virus: a tool for research and vaccine development. Science 252: 1662-1667 [Abstract]  
  • Bosch, M., Earl, P., Fargnoli, K, Picciafuoco, S, Giombini, F, Wong-Staal, F, Franchini, G (1989). Identification of the fusion peptide of primate immunodeficiency viruses. Science 244: 694-697 [Abstract]  
  • Xiong, C, Levis, R, Shen, P, Schlesinger, S, Rice, C., Huang, H. (1989). Sindbis virus: an efficient, broad host range vector for gene expression in animal cells. Science 243: 1188-1191 [Abstract]  
  • Earl, P., Moss, B, Morrison, R., Wehrly, K, Nishio, J, Chesebro, B (1986). T-lymphocyte priming and protection against Friend leukemia by vaccinia-retrovirus env gene recombinant. Science 234: 728-731 [Abstract]  
  • Abraham, J.A., Whang, J.L., Tumolo, A., Mergia, A., Fiddes, J.C. (1986). Human Basic Fibroblast Growth Factor: Nucleotide Sequence, Genomic Organization, and Expression in Mammalian Cells. Cold Spring Harb Symp Quant Biol 51: 657-668 [Abstract]  
  • Roizman, B, Jenkins, F. (1985). Genetic engineering of novel genomes of large DNA viruses. Science 229: 1208-1214 [Abstract]  
  • STRAUS, S. E., ROONEY, J. F., SEVER, J. L., SEIDLIN, M., NUSINOFF-LEHRMAN, S., CREMER, K. (1985). Herpes Simplex Virus Infection: Biology, Treatment, and Prevention. ANN INTERN MED 103: 404-419 [Abstract]  
  • Cremer, K., Mackett, M, Wohlenberg, C, Notkins, A., Moss, B (1985). Vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D prevents latent herpes in mice. Science 228: 737-740 [Abstract]  
  • Mackett, M, Yilma, T, Rose, J., Moss, B (1985). Vaccinia virus recombinants: expression of VSV genes and protective immunization of mice and cattle. Science 227: 433-435 [Abstract]  
  • Smith, G., Godson, G., Nussenzweig, V, Nussenzweig, R., Barnwell, J, Moss, B (1984). Plasmodium knowlesi sporozoite antigen: expression by infectious recombinant vaccinia virus. Science 224: 397-399 [Abstract]  
  • Belz, G. T., Stevenson, P. G., Castrucci, M. R., Altman, J. D., Doherty, P. C. (2000). Postexposure vaccination massively increases the prevalence of gamma -herpesvirus-specific CD8+ T cells but confers minimal survival advantage on CD4-deficient mice. Proc. Natl. Acad. Sci. USA 97: 2725-2730 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»